High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index; 1 of the 5 sources its claims cite were checked for support.
Abstract
A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99 x 10(-16)). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53 x 10(-12)), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80 x 10(-13). Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE-associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
Overview
CoChat Summary
## TL;DR
This study used high-density MHC SNP screening plus HLA-DRB1 genotyping in European-ancestry SLE cases/families to show that multiple, independent susceptibility regions contribute to SLE risk. The strongest signals were at HLA-DRB1, with the top SNP rs3117103 also showing strong association, and follow-up conditional analyses supported additional effects in OR2H2, CREBL1, MICB, and DQB2.
## Key findings
- In 1,610 Caucasian SLE cases and 1,470 parents, the strongest HLA-DRB1 associations were for DRB1*0301 (OR = 2.21, p = 2.53×10−12), DRB1*1401 (OR = 0.50, p = 0.0002), and DRB1*1501 (OR = 1.39, p = 0.0032).
- Among 1,974 MHC SNPs passing quality control, the strongest SNP association was rs3117103 (OR = 2.44, p = 2.80×10−13); the paper also reports rs3117103 remained strong in a more homogeneous Northern European subset (OR = 2.49, p = 1.62×10−13).
- Conditional haplotype and stepwise logistic regression analyses identified independent signals in multiple regions: OR2H2 (rs362521, p = 0.006), CREBL1 (rs8283, p = 0.01), DQB2 (rs7769979, p = 0.003; rs10947345, p = 0.0004), and MICB (rs3828903, p = 0.006).
- The strongest associated extended haplotype contained DRB1*0301 (15% transmitted vs. 6% non-transmitted; OR = 2.63, p = 8.32×10−15); a second associated haplotype contained DRB1*1501 (9% transmitted vs. 6% non-transmitted; OR = 1.54, p = 0.0025).
## Methods
- Family-based and case-based genetic association study of 1,610 Caucasian SLE cases and 1,470 parents from trio families; cases came from three independent collections, and all SLE cases met American College of Rheumatology criteria.
- Genotyping included HLA-DRB1, 2,360 MHC SNPs on Illumina’s Combined MHC panel, and 384 ancestry informative markers; after quality control, 2,873 samples and 1,974 MHC SNPs remained for analysis.
- Main analyses used RPE, univariate association tests, TDT, conditional haplotype methods, stepwise logistic regression, haplotype analysis, LD analysis, and BEAGLE/PHASE/UNPHASED/WHAP/PLINK/STATA/SAS as described in the paper.
## Limitations
- The paper states that MHC coverage was not comprehensive: the marker set was not designed to directly assess rare variants or multi-allelic markers such as indels or copy-number variants, and it did not characterize other classical HLA genes besides HLA-DRB1.
- The authors note they cannot determine which associated variants are causal versus proxies in LD, so the reported associations are not proof of causation.
- Evident from the text: the study analyzed only European-ancestry/Caucasian samples, and the authors explicitly say non-European populations were not examined and should be a focus for future work.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
1 Valid · 0 Not valid · 1 Not checked · 52 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21.”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
What the sources say
- Not checked — no full text of the sourcecites [8] Graham RR Ortmann WA Langefeld CD Jawaheer D Selby SA 2002 Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 71 543 553 12145745 PMC379191 source
- Not checked — no full text of the sourcecites [9] Graham RR Ortmann W Rodine P Espe K Langefeld C 2007 Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 15 823 830 17406641 source
- Supportedcites [10] Harley JB Alarcon-Riquelme ME Criswell LA Jacob CO Kimberly RP 2008 Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40 204 210 18204446 PMC3712260 source
The genome-wide association results report the strongest SLE association in the HLA (MHC) region at chromosome 6p21.3, with two partially independent effects there. This supports a substantial genetic contribution from that region, without identifying the specific causal genes. (LLM, conf=0.90)
plainstates a causen = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004).”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
plainstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions.”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
boostedstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032).”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
plainstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004).”
§ High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions > Abstract A substantial genetic contribution to systemic lupus erythematosus (SLE) risk is conferred by major histocompatibility complex (MHC) gene(s) on chromosome 6p21. Previous studies in SLE have lacked statistical power and genetic resolution to fully define MHC influences. We characterized 1,610 Caucasian SLE cases and 1,470 parents for 1,974 MHC SNPs, the highly polymorphic HLA-DRB1 locus, and a panel of ancestry informative markers. Single-marker analyses revealed strong signals for SNPs within several MHC regions, as well as with HLA-DRB1 (global p = 9.99×10−16). The most strongly associated DRB1 alleles were: *0301 (odds ratio, OR = 2.21, p = 2.53×10−12), *1401 (OR = 0.50, p = 0.0002), and *1501 (OR = 1.39, p = 0.0032). The MHC region SNP demonstrating the strongest evidence of association with SLE was rs3117103, with OR = 2.44 and p = 2.80×10−13. Conditional haplotype and stepwise logistic regression analyses identified strong evidence for association between SLE and the extended class I, class I, class III, class II, and the extended class II MHC regions. Sequential removal of SLE–associated DRB1 haplotypes revealed independent effects due to variation within OR2H2 (extended class I, rs362521, p = 0.006), CREBL1 (class III, rs8283, p = 0.01), and DQB2 (class II, rs7769979, p = 0.003, and rs10947345, p = 0.0004). Further, conditional haplotype analyses demonstrated that variation within MICB (class I, rs3828903, p = 0.006) also contributes to SLE risk independent of HLA-DRB1*0301. Our results for the first time delineate with high resolution several MHC regions with independent contributions to SLE risk. We provide a list of candidate variants based on biologic and functional considerations that may be causally related to SLE risk and warrant further investigation.
boostedstates an associationn = 1,610 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
26 more claims
Create a free account to see all 54 claims and every source verdict.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 2×
“Transmission disequilibrium testing (TDT) [21] analyses of individual markers were performed using the PLINK program [22].”
MethodHaploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,525
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519 · cited 2×
“of Rheumatology classification criteria for SLE [35,36].”
BackgroundHochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Browning, S. R., & Browning, B. L. (2007) · The American Journal of Human Genetics · doi:10.1086/521987 · Cited by 3,210 · cited 1×
“Missing genotypes for cases and non-transmitted controls were inferred using default parameters in BEAGLE v2.1.3”
MethodInfluentialEfficiency and power in genetic association studies
de Bakker, P. I. W., Yelensky, R., Pe'er, I., Gabriel, S. B., Daly, M. J., & Altshuler, D. (2005) · Nature Genetics · doi:10.1038/ng1669 · Cited by 1,688
The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309 · cited 1×
“More recently, genome wide association scans in SLE also underscore the importance of the MHC [10,11,12].”
BackgroundSelf-citationGene map of the extended human MHC
Horton, R., Wilming, L., Rand, V., Lovering, R. C., Bruford, E. A., Khodiyar, V. K., Lush, M. J., Povey, S., Talbot, C. C., Wright, M. W., et al. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1489 · Cited by 1,198 · cited 1×
“, spanning a total of 7.6 Mb and comprised of five subregions that include the original ‘classical’ MHC”
BackgroundInfluentialPedigree disequilibrium tests for multilocus haplotypes.
Dudbridge, F. (2003) · Genetic Epidemiology · doi:10.1002/gepi.10252 · Cited by 1,135 · cited 1×
“Similarly, for the multi-allelic HLA-DRB1 locus, all pairwise measures of LD with MHC region SNPs were determined using UNPHASED (LD option) [42].”
MethodComplete sequence and gene map of a human major histocompatibility complex
The MHC sequencing consortium (1999) · Nature · doi:10.1038/44853 · Cited by 1,065
Cited by
Erho, N., Crisan, A., Vergara, I. A., Mitra, A. P., Ghadessi, M., Buerki, C., Bergstralh, E. J., Kollmeyer, T., Fink, S., Haddad, Z., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066855 · Cited by 644
Genome-wide association study identifies susceptibility loci for IgA nephropathy
Gharavi, A. G., Kiryluk, K., Choi, M., Li, Y., Hou, P., Xie, J., Sanna-Cherchi, S., Men, C. J., Julian, B. A., Wyatt, R. J., et al. (2011) · Nature Genetics · doi:10.1038/ng.787 · Cited by 624
Kiryluk, K., Li, Y., Sanna-Cherchi, S., Rohanizadegan, M., Suzuki, H., Eitner, F., Snyder, H. J., Choi, M., Hou, P., Scolari, F., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002765 · Cited by 383
“These findings are consistent with previous studies of IgAN [15,21] and other autoimmune diseases [22,23,24,25], highlighting the complexity of associations in the MHC region.”
ResultGenetic susceptibility to systemic lupus erythematosus in the genomic era
Deng, Y., & Tsao, B. P. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.176 · Cited by 379
“Furthermore, a study that screened the MHC genomic region of 1,610 European-derived patients with SLE (and 1,470 of their parents) for 1,974 high-density SNPs identified multiple independent loci associated with SLE, including DRB1 a 0301 , DRB1 a 1401 , DRB1 a 1501 and the DQB2 alleles, CREBL1 , MICB and OR2H2”
BackgroundGenetics and pathogenesis of systemic lupus erythematosus and lupus nephritis
Mohan, C., & Putterman, C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.33 · Cited by 377
B cells as therapeutic targets in SLE
Sanz, I., & Lee, F. E.-H. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.68 · Cited by 261
“Notably, all B-cell-targeting interventions will have to contend with one of the main obstacles faced in the treatment of SLE—namely, the high degree of disease diversity, which may be mediated at least in part by genetic heterogeneity”
BackgroundChung, S. A., Taylor, K. E., Graham, R. R., Nititham, J., Lee, A. T., Ortmann, W. A., Jacob, C. O., Alarcón-Riquelme, M. E., Tsao, B. P., Harley, J. B., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001323 · Cited by 213
Self-citationSelective IgA Deficiency in Autoimmune Diseases
Wang, N., Shen, N., Vyse, T. J., Anand, V., Gunnarson, I., Sturfelt, G., Rantapää-Dahlqvist, S., Elvin, K., Truedsson, L., Andersson, B. A., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00195 · Cited by 203
Self-citationLi, H., Boulougoura, A., Endo, Y., & Tsokos, G. C. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102870 · Cited by 201
Morris, D. L., Taylor, K. E., Fernando, M. M. A., Nititham, J., Alarcón-Riquelme, M. E., Barcellos, L. F., Behrens, T. W., Cotsapas, C., Gaffney, P. M., Graham, R. R., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.08.026 · Cited by 179
“There have also been associations with other alleles such as HLA-DRB1*08:01(8) and HLA-DRB1*14:01.(7) However, because of strong LD in the class II region (HLA-DR and HLA-DQ), HLA-DRB1 alleles are correlated with alleles of the class II loci HLA-DQA1 (MIM 146880)”
BackgroundMethodInfluentialSelf-citationLupus nephritis susceptibility loci in women with systemic lupus erythematosus.
Chung, S. A., Brown, E., Williams, A. H., Ramos, P. S., Berthier, C., Bhangale, T., Alarconriquelme, M., Behrens, T., Criswell, L., Graham, D., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050446 · Cited by 130
Self-citationPathogenesis of Immunoglobulin A Nephropathy: Recent Insight from Genetic Studies
Kiryluk, K., Novák, J., & Gharavi, A. G. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041811-142014 · Cited by 133
“The DRB1*1501-DQB1*0602 haplotype is common in the European and Asian populations and has been implicated in the risk of multiple disorders of immunity and response to environment: it has been associated with increased risk of multiple sclerosis (54), systemic lupus erythematosus (55), narcolepsy (56), and hepatotoxic…”
BackgroundGianfrancesco, M. A., Acuna, B., Shen, L., Briggs, F. B. S., Quach, H., Bellesis, K. H., Bernstein, A., Hedstrom, A. K., Kockum, I., Alfredsson, L., et al. (2014) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2014.01.002 · Cited by 124
Self-citationAdrianto, I., Lin, C. P., Hale, J. J., Levin, A. M., Datta, I., Parker, R., Adler, A., Kelly, J. A., Kaufman, K. M., Lessard, C. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043907 · Cited by 137
“NOTCH4 has also been associated with neonatal lupus [42], multiple sclerosis [43], systemic sclerosis [44], and other immune-related disorders [45,46,47,48].”
BackgroundSelf-citationRubicz, R. C., Yolken, R. H., Drigalenko, E. I., Carless, M. A., Dyer, T. D., Bauman, L., Melton, P. E., Kent, J. W., Harley, J. B., Curran, J. E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003147 · Cited by 125
Self-citationGenetics, genomics, and evolutionary biology of NKG 2D ligands
Carapito, R., & Bahram, S. (2015) · Immunological Reviews · doi:10.1111/imr.12328 · Cited by 130
“MICB alleles have been linked to multiple sclerosis (211), celiac disease (212, 213), systemic lupus erythematosus (214, 215), cardiac manifestations of neonatal lupus (216), rheumatoid arthritis (217), and psoriasis (208).”
BackgroundSreih, A. G., Ezzeddine, R., Leng, L., LaChance, A., Yu, G., Mizue, Y., Subrahmanyan, L., Pons‐Estel, B. A., Abelson, A.-K., Gunnarsson, I., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30624 · Cited by 115
Self-citationThe HLA-DRβ1 amino acid positions 11–13–26 explain the majority of SLE–MHC associations
Kim, K.-W., Bang, S., Lee, H. S., Okada, Y., Han, B., Saw, W., Teo, Y. Y., & Bae, S. (2014) · Nature Communications · doi:10.1038/ncomms6902 · Cited by 109
Genetic Factors Predisposing to Systemic Lupus Erythematosus and Lupus Nephritis
Ramos, P. S., Brown, E. E., Kimberly, R. P., & Langefeld, C. D. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.01.007 · Cited by 125
cAMP responsive element modulator: a critical regulator of cytokine production
Rauen, T., Hedrich, C. M., Tenbrock, K., & Tsokos, G. C. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.001 · Cited by 100
“All members share high sequence homology within their DNA binding domains (a basic leucine zipper domain) and bind to the common palindromic consensus element 5′-TGACGTCA-3′, the cAMP responsive element (CRE), or its 5′-half-site [16].”
BackgroundSarig, O., Bercovici, S., Zoller, L., Goldberg, I., Indelman, M., Nahum, S., Israeli, S., Sagiv, N., de Morentin, H. M., Katz, O., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.46 · Cited by 101
“The other three gene loci have not yet been reported in association with PV but harbor variants predisposing to other inflammatory and/or skin disorders (Simmonds et al., 2006; Fernandez-Morera et al., 2008; Okuyama et al., 2008; Barcellos et al., 2009; Cialfi et al., 2010; Clancy et al., 2010; Hsueh et al., 2010; Jin…”
BackgroundRecent advances in the genetics of systemic lupus erythematosus
Thibault Flesher, D. L., Sun, X., Behrens, T. W., Graham, R. R., & Criswell, L. A. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.8 · Cited by 93
Self-citationMHC associations with clinical and autoantibody manifestations in European SLE
Morris, D., Fernando, M., Taylor, K., Chung, S., Nititham, J., Alarcón-Riquelme, M., Barcellos, L., Behrens, T., Cotsapas, C., Gaffney, P., et al. (2014) · Genes and Immunity · doi:10.1038/gene.2014.6 · Cited by 97
Self-citationTargeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
Oon, S., Wilson, N. J., & Wicks, I. P. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.26 · Cited by 97
The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity
Lauschke, V., & Ingelman-Sundberg, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101714 · Cited by 88
Recent advances in the genetics of sarcoidosis
Spagnolo, P., & Grünewald, J. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101532 · Cited by 90
Shimane, K., Kochi, Y., Suzuki, A., Okada, Y., Ishii, T., Horita, T., Saito, K., Okamoto, A., Nishimoto, N., Myouzen, K., et al. (2013) · Rheumatology · doi:10.1093/rheumatology/kes427 · Cited by 87
Fernando, M. M. A., Freudenberg, J., Lee, A., Morris, D. L., Boteva, L., Rhodes, B., González‐Escribano, M. F., López‐Nevot, M. Á., Navarra, S., Gregersen, P. K., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200808 · Cited by 84
“These data contrast with those of northern European lupus cohorts where HLA-DRB1*08:01 is uncommon and not associated with SLE [4-5].”
Vaughn, S. E., Kottyan, L. C., Munroe, M. E., & Harley, J. B. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212095 · Cited by 72
“27 10 51 EU, AS, AA, HA [6, 7, 12, 16, 34, 35, 39, 40] rs1270942 (G) [6] 0.”
Self-citationPsoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease
Chen, H., Hayashi, G., Lai, O., Dilthey, A., Kuebler, P., Wong, T. V., Martin, M. P., Fernández-Viña, M., McVean, G., Wabl, M. R., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002514 · Cited by 73
“The method begins with an empty model to which variables are added in an iterative process as described by Barcellos et al [71].”
MethodGianfrancesco, M. A., Glymour, M. M., Walter, S., Rhead, B., Shao, X., Shen, L., Quach, H., Hubbard, A., Jónsdóttir, I., Stefánsson, K., et al. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kww120 · Cited by 69
Self-citationLundström, E., Gustafsson, J. T., Jönsen, A., Leonard, D., Zickert, A., Elvin, K., Sturfelt, G. K., Nordmark, G., Bengtsson, A. A., Sundin, U., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201760 · Cited by 70
Koga, M., Kawasaki, A., Ito, I., Furuya, T., Ohashi, J., Kyogoku, C., Ito, S., Hayashi, T., Matsumoto, I., Kusaoi, M., et al. (2011) · Journal of Human Genetics · doi:10.1038/jhg.2011.49 · Cited by 72
Genome‐wide association study identifies new susceptibility loci for cutaneous lupus erythematosus
Kunz, M., König, I. R., Schillert, A., Kruppa, J., Ziegler, A., Grallert, H., Müller‐Nurasyid, M., Lieb, W., Franke, A., Ranki, A., et al. (2015) · Experimental Dermatology · doi:10.1111/exd.12708 · Cited by 65
Flåm, S. T., Gunnarsson, R., Garen, T., et al. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu310 · Cited by 60
European genetic ancestry is associated with a decreased risk of lupus nephritis
Richman, I. B., Taylor, K. E., Chung, S. A., Trupin, L. S., Petri, M., Yelin, E. H., Graham, R., Lee, A., Behrens, T. W., Gregersen, P. K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34567 · Cited by 58
“Like other SLE risk alleles, these HLA types may not only confer risk for the development of SLE, but also renal disease, and thus were chosen as candidate genes (21).”
BackgroundSelf-citationHLA Immune Function Genes in Autism
Torres, A. R., Westover, J. B., & Rosenspire, A. J. (2012) · Autism Research and Treatment · doi:10.1155/2012/959073 · Cited by 56
Nyaga, D. M., Vickers, M. H., Jefferies, C., Perry, J. K., & O'Sullivan, J. M. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00535 · Cited by 63
“(2009) who identified the existence of multiple, independent disease susceptibility regions within the HLA locus (Barcellos et al., 2009).”
BackgroundSystemic lupus erythematosus genetics: insights into pathogenesis and implications for therapy
Ghodke‐Puranik, Y., Olferiev, M., & Crow, M. K. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01152-2 · Cited by 72
“The MHC region stands out as the locus with the strongest genetic association across many autoimmune diseases 74,75 .”
Role of MHC-Linked Susceptibility Genes in the Pathogenesis of Human and Murine Lupus
Relle, M., & Schwarting, A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/584374 · Cited by 57
“GWAS in European- or East Asian-ancestry populations [91– 94] and high-density screenings [20, 95] have identified several independent SNPs in the MHC region associated with SLE.”
BackgroundRole of theMICApolymorphism in systemic lupus erythematosus: MICAPolymorphism in SLE
Yoshida, K., Komai, K., Shiozawa, K., Mashida, A., Horiuchi, T., Tanaka, Y., Nose, M., Hashiramoto, A., & Shiozawa, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30501 · Cited by 43
Systemic lupus erythematosus diagnostics in the ‘omics’ era
Arriens, C., & Mohan, C. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.59 · Cited by 45
Pedroza, L. S. R. D. A., Sauma, M. F. L. C., Vasconcelos, J., Takeshita, L., Ribeiro-Rodrigues, E., Sastre, D., Barbosa, C., Chies, J. A. B., Veit, T. D., Lima, C., et al. (2011) · Lupus · doi:10.1177/0961203310385266 · Cited by 41
Lucena‐Silva, N., de Souza, V. S. B., Gomes, R. G., Fantinatti, A., Muniz, Y. C. N., de Albuquerque, R. S., Monteiro, A. R., Diniz, G. T. N., Coêlho, M. R. C. D., Mendes‐Junior, C. T., et al. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120814 · Cited by 39
Polymorphisms in the Hsp70 gene locus are genetically associated with systemic lupus erythematosus
Fürnrohr, B. G., Wach, S., Kelly, J. A., Haslbeck, M., Weber, C., Stach, C. M., Hueber, A. J., Graef, D., Spriewald, B. M., Manger, K., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122630 · Cited by 37
“mRNA is functionally relevant for the pathogenesis of SLE remains to be elucidated. Because of the extent of LD, we are currently unable to rule out indirect effects that might arise from potentially causal variants of Hsp70-3 or other unknown factors. As we have analysed the expression of Hsp70 genes in PBMCs, a tiss…”
Self-citationMicrobiota — an amplifier of autoimmunity
Vogelzang, A., Guerrini, M. M., Minato, N., & Fagarasan, S. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.003 · Cited by 41
The 330 risk loci known for systemic lupus erythematosus (SLE): a review
Laurynenka, V., & Harley, J. B. (2024) · Frontiers in Lupus · doi:10.3389/flupu.2024.1398035 · Cited by 47
Self-citationSingh, N., Traisak, P., Martin, K. A., Kaplan, M. J., Cohen, P. L., & Denny, M. F. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4681 · Cited by 43
“Recent high-resolution mapping of the MHC locus has identified a susceptibility interval that includes the DNA repair gene MSH5, consistent with a role for DNA damage and repair in the development of SLE [94,97,98].”
Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases
Kim, S. J. (2015) · Immunologic Research · doi:10.1007/s12026-015-8694-5 · Cited by 38
“This study confirmed the genes that were previously identified to be associated with SLE, for example human leukocyte antigen (HLA) molecules [25, 26].”
BackgroundAhn, R. S., Ding, Y. C., Murray, J. A., Fasano, A., Green, P. H. R., Neuhausen, S. L., & Garner, C. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036926 · Cited by 39
MHC region and risk of systemic lupus erythematosus in African American women
Ruiz-Narváez, E., Fraser, P. A., Palmer, J. R., Cupples, L. A., Reich, D., Wang, Y. A., Rioux, J. D., & Rosenberg, L. A. (2011) · Human Genetics · doi:10.1007/s00439-011-1045-2 · Cited by 36
“Recent GWAS (Graham et al. 2008; Han et al. 2009; Harley et al. 2008; Hom et al. 2008) and high-density screenings (Barcellos et al. 2009; Rioux et al. 2009b) have identiWed several independent single nucleotide polymorphisms (SNPs) in the MHC region associated with risk of SLE.”
MethodInfluentialDeshmukh, U. S., Sim, D., Dai, C., Kannapell, C. C., Gaskin, F., Rajagopalan, G., David, C. S., & Fu, S. M. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.07.002 · Cited by 35
McCaffrey, T. A., Tziros, C., Lewis, J. F., et al. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.6058 · Cited by 30
Open reading frames associated with cancer in the dark matter of the human genome.
Delgado, A. P., Brandao, P., Chapado, M. J., Hamid, S., & Narayanan, R. (2014) · PubMed · Cited by 30
Kaiser, R., & Criswell, L. A. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283361943 · Cited by 30
Self-citationSLE-Associated Defects Promote Altered T Cell Function
Crispín, J. C., Hedrich, C. M., Suárez‐Fueyo, A., Comte, D., & Tsokos, G. C. (2017) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018025213 · Cited by 33
Lou, Q., Li, Z., Teng, Y., Xie, Q.-M., Zhang, M., Huang, S.-W., Li, W.-F., Chen, Y., Fa-ming, P., Xu, S.-Q., et al. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05195-0 · Cited by 27
The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus
Bronson, P., Goldstein, B., Ramsay, P., Beckman, K. B., Noble, J., Lane, J. A., Seldin, M., Kelly, J., Harley, J., Moser, K., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.36 · Cited by 31
Self-citationKang, H.-K., Chiang, M.-Y., Ecklund, D., Zhang, L., Ramsey‐Goldman, R., & Datta, S. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200452 · Cited by 28
“genes are major determinants of lupus susceptibility, underscoring the importance of autoantigen presentation by class II molecules to autoreactive Th cells in initiating the disease (1).”
BackgroundAssociation Analysis of the MHC in Lupus Nephritis.
Xu, R., Li, Q.-B., Liu, R.-J., Shen, J., Li, M., Zhao, M.-H., Wang, M., Liao, Q., Mao, H.-P., Li, Z.-J., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016121331 · Cited by 23
Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism
Jahromi, M. M. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.001 · Cited by 24
The lupus susceptibility allele DRB1*03:01 encodes a disease-driving epitope
Scavuzzi, B. M., van Drongelen, V., Kaur, B., Fox, J. C., Liu, J. J., Mesquita‐Ferrari, R. A., Kahlenberg, J. M., Farkash, E. A., Benavides, F. J., Miller, F. W., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03717-x · Cited by 25
Cruz, G., Shao, X., Quach, H., Ho, K. A., Sterba, K., Noble, J. A., Patsopoulos, N. A., Busch, M. P., Triulzi, D. J., Wong, W. S. W., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210662 · Cited by 22
Self-citationEpidemiology of pediatric multiple sclerosis, neuromyelitis optica, and optic neuritis in Taiwan
Lin, W., Wang, H.-P., Chen, H., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09647-9 · Cited by 21
CHOWDHARY, V. R., Dai, C., Tilahun, A. Y., Hanson, J. A., Smart, M. K., Grande, J. P., Rajagopalan, G., Fu, S. M., & David, C. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501073 · Cited by 21
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus
Gambino, C. M., Bona, D. D., Aiello, A., Carru, C., Duro, G., Guggino, G., Ferrante, A., Zinellu, A., Caruso, C., Candore, G., et al. (2018) · Human Immunology · doi:10.1016/j.humimm.2018.01.005 · Cited by 22
Han, L., Chen, C., Lu, X., Song, Y., Zhang, Z., Zeng, C., Chiu, R., Li, L., Xu, M., He, C., et al. (2020) · Genomics · doi:10.1016/j.ygeno.2020.11.014 · Cited by 21
Kruppel-like factor4 regulates PRDM1 expression through binding to an autoimmune risk allele
Jang, S. H., Chen, H., Gregersen, P. K., Diamond, B., & Kim, S. J. (2017) · JCI Insight · doi:10.1172/jci.insight.89569 · Cited by 17
Mowry, E. M., Hedström, A. K., Gianfrancesco, M. A., Shao, X., Schaefer, C. A., Shen, L., Bellesis, K. H., Briggs, F. B. S., Olsson, T. P., Alfredsson, L. S., et al. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.06.009 · Cited by 17
Self-citationLiu, Z., Yu, Y., Yue, Y., et al. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190424130809 · Cited by 17
Gianfrancesco, M., Balzer, L., Taylor, K., Trupin, L., Nititham, J., Seldin, M., Singer, A., Criswell, L., & Barcellos, L. (2016) · Genes and Immunity · doi:10.1038/gene.2016.33 · Cited by 16
Self-citationMoudi, M., Sargazi, S., Nia, M. H., Saravani, R., Shirvaliloo, M., & Shakiba, M. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01616-6 · Cited by 18
NKG2D‐ligands: Putting everything under the same umbrella can be misleading
Campos‐Silva, C., Kramer, M. K., & Valés‐Gómez, M. (2018) · HLA · doi:10.1111/tan.13246 · Cited by 18
A Child’s HLA-DRB1 genotype increases maternal risk of systemic lupus erythematosus
Cruz, G., Shao, X., Quach, H., Ho, K. A., Sterba, K., Noble, J. A., Patsopoulos, N. A., Busch, M. P., Triulzi, D. J., Wong, W. S. W., et al. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.06.017 · Cited by 14
Self-citationRhodes, B., & Vyse, T. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00080-x · Cited by 18
MIC gene polymorphism and haplotype diversity in Zhuang nationality of Southern China
Chen, E., Lin, L., Chen, E., et al. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.08.203 · Cited by 14
Zhou, J., Li, X., Gao, X., Wei, Y., Ye, L., Liu, S., Ye, J., Qiu, Y., Zheng, X., Chen, C., et al. (2023) · Gerontology · doi:10.1159/000530665 · Cited by 13
Du, W., Shen, T., Li, H., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0476-8 · Cited by 13
Facts and controversies in mixed connective tissue disease
Martínez‐Barrio, J., Valor, L., & López-Longo, F. J. (2017) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2017.11.029 · Cited by 13
Hachicha, H., Kammoun, A., Mahfoudh, N., et al. (2018) · PubMed · Cited by 13
Saxena, A., McDonnell, E., Ramos, P. S., Sajuthi, S. P., Marion, M., Langefeld, C., Buyon, J., & Clancy, R. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33366 · Cited by 8
Hechos y controversias en la enfermedad mixta del tejido conectivo
Martínez‐Barrio, J., Valor, L., & López-Longo, F. J. (2017) · Medicina Clínica · doi:10.1016/j.medcli.2017.06.066 · Cited by 12
Datta, S. K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629807 · Cited by 13
Clinical Perspectives on Lupus Genetics
James, J. A. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.04.002 · Cited by 26
Villalvazo, P., Carriazo, S. M., Rojas-Rivera, J. E., Ramos, A. M., Ortíz, A., & Pérez-Gómez, M. V. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac152 · Cited by 14
MIC gene polymorphism and haplotype diversity in Li nationality of Southern China
Lin, L., Yang, W., Chen, E., et al. (2014) · Tissue Antigens · doi:10.1111/tan.12449 · Cited by 10
Bronson, P. G., Komorowski, L. K., Ramsay, P. P., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27426 · Cited by 10
“Families were enrolled through the University of California, San Francisco (UCSF) (n = 314), the University of Minnesota (n = 233), and the Oklahoma Medical Research Foundation (n = 160), as previously described (6).”
MethodSelf-citationPsoriasis and Lupus Erythematosus—Similarities and Differences between Two Autoimmune Diseases
Fijałkowska, A., Wojtania, J., Woźniacka, A. J., & Robak, E. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154361 · Cited by 12
Renaudineau, Y., Charras, A., Natoli, V., Congy‐Jolivet, N., Haldenby, S. T., Liu, X., Fang, Y., Smith, E. M. D., Beresford, M. W., Hedrich, C. M., et al. (2025) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2025.100268 · Cited by 12
Solving the genetic puzzle of systemic lupus erythematosus
Yang, W., & Lau, Y. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2947-8 · Cited by 9
“[101] found that the highest association signal was in MSH5 in the class III region and from RDBP and C6orf10 [12], independent of the effect from HLADR and HLA-DQ genes.”
BackgroundHLA-DRB1 gene polymorphism is associated with idiopathic dilated cardiomyopathy: a meta-analysis
Deng, J.-L., Luo, R., & Li, X. (2011) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328349424b · Cited by 7
Bernstein, H., Kirches, E., Bogerts, B., Lendeckel, U., Keilhoff, G., Zempeltzi, M. M., Steiner, J. H., Tenbrock, K., Dobrowolny, H., Kyttaris, V. C., et al. (2013) · Amino Acids · doi:10.1007/s00726-013-1601-2 · Cited by 7
Atlas of the Open Reading Frames in Human Diseases: Dark Matter of the Human Genome
Narayanan, R. (2015) · MOJ Proteomics & Bioinformatics · doi:10.15406/mojpb.2015.02.00036 · Cited by 4
“The C6orf100 is associated with Graves' disease, Systemic Lupus and Autoimmune endocrine diseases [66,67].”
BackgroundNakabayashi, K., & Shirasawa, S. (2010) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.33.66 · Cited by 7
Zhao, L., 陕西师范大学生命科学学院, 陕. 西., Yuan, J., Wang, G., Jing, H., Huang, C., Xu, L., Xu, X., Sun, T., Wu, C., et al. (2024) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2024.027 · Cited by 7
“…and other bats, respectively), a gene specifically expressed in human epidermal Langerhans cells (Lenormand et al., 2012) and associated with systemic lupus erythematosus (Barcellos et al., 2009), rheumatoid arthritis (Kochi et al., 2004), and hepatitis B (Chang et al., 2014; Xu et al., 2017).”
BackgroundUrayama, K. Y., Chokkalingam, A. P., Metayer, C., Hansen, H. M., May, S. L., Ramsay, P. P., Wiemels, J. L., Wiencke, J. K., Trachtenberg, E., Thompson, P. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072557 · Cited by 5
“Evidence of susceptibility associated with xMHC loci has been identified in several autoimmune, malignant and infectious diseases, including asthma, Hodgkin and nonHodgkin lymphoma, hepatitis B and HIV infection and others [4,5,6,7].”
BackgroundSelf-citationZhang, Y.-M., Zhou, X.-J., Cheng, F.-J., Qi, Y.-Y., Hou, P., Zhao, M.-H., & Zhang, H. (2016) · Journal of Immunological Research · doi:10.1155/2016/1343760 · Cited by 8
Progress towards precision medicine for lupus: the role of genetic biomarkers
Anaya, J., Leon, K. J., Rojas, M., Rodríguez, Y., Pacheco, Y., Acosta‐Ampudia, Y., Monsalve, D. M., & Ramírez-Santana, C. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1448266 · Cited by 6
Association study between TRIM26 polymorphisms and risk of aspirin-exacerbated respiratory disease
Shin, H. D. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.898 · Cited by 6
Comprehensive analysis of RNA-5-methylcytosine modification in breast cancer brain metastasis
Cai, P., Li, J., An, M., et al. (2024) · Future Oncology · doi:10.1080/14796694.2024.2405459 · Cited by 4
Metadata
- Authors
- Barcellos, L. F., May, S. L., Ramsay, P. P., Quach, H. L., Lane, J. A., Nititham, J., Noble, J. A., Taylor, K. E., Quach, D. L., Chung, S. A., Kelly, J. A., Moser, K. L., Behrens, T. W., Seldin, M. F., Thomson, G., Harley, J. B., Gaffney, P. M., & Criswell, L. A.
- Affiliations
- University of California, Berkeley (US)
- UCSF Benioff Children's Hospital (US)
- University of California, San Francisco (US)
- Oklahoma Medical Research Foundation (US)
- Genentech (US)
- University of California, Davis (US)
- Corresponding author
- Criswell, Lindsey A.
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-10-23
- Volume
- 5
- Issue
- 10
- Pages
- e1000696
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC2758598
- OpenAlex
- W2010016129
- Semantic Scholar
- e76a1b3dcde88cab4e7473278eacb92ff1cc994e
- Cited by
- 131
- References
- 50
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 8 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 13 · 2012: 19
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Veterans Affairs
- Lupus Research Alliance
- National Institutes of Health (n01ar62277-9-0-1, n01ai40076-11-0-2, 5m01rr000079-42, AI063274, AI24717, AI40076, AI62629)
- University of California, San Francisco
- National Institute of Allergy and Infectious Diseases (AI62629, AI-31584, AI-24717, R01AI063274, R37AI024717, R01AI031584, AI53747, AI-063274, R21AI053747, R56AI063274, U19AI062629, N01 AI040076, R01AI024717)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052125, AR19084, R01AR042460, R01AR043274, AR-052300, AR043274, AR02175, R01AR052300, P30AR053483, AR 42460, N01-AR062277, AR22804, AR052125, K24AR002175, P50AR048940, AR 48940)
- National Institute of Dental and Craniofacial Research (DE15223, R01DE015223)
- National Center for Research Resources (RR20143, P20RR020143, M01-RR000079)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- systemic lupus erythematosus, major histocompatibility complex, HLA-DRB1, HLA-DRB1*0301, HLA-DRB1*1501, MICB, ancestry informative markers, haplotype association, risk genes
- MeSH terms
- Adult, Female, HLA-DR Antigens, Humans, Lupus Erythematosus, Systemic, Major Histocompatibility Complex, Male, Middle Aged, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, White People, Young Adult, HLA-DRB1 Chains
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.